ReviewPharmaceuticals (Basel, Switzerland)2026
Oral GLP-1-Based Therapeutics in the Obesity-Metabolic Syndrome-Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies.
Syed Arman Rabbani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.